US Bancorp’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-726
Closed -$1.6K 4237
2025
Q1
$1.6K Buy
+726
New +$1.41K ﹤0.01% 3920
2022
Q4
Sell
-4,204
Closed -$18K 4201
2022
Q3
$18K Buy
+4,204
New +$16.4K ﹤0.01% 3065
2021
Q2
Sell
-350
Closed -$6K 4033
2021
Q1
$6K Hold
350
﹤0.01% 3449
2020
Q4
$7K Buy
350
+67
+24% +$1.17K ﹤0.01% 3307
2020
Q3
$4K Hold
283
﹤0.01% 3356
2020
Q2
$4K Sell
283
-217
-43% -$3.56K ﹤0.01% 3375
2020
Q1
$6K Buy
500
+300
+150% +$5.64K ﹤0.01% 3187
2019
Q4
$5K Hold
200
﹤0.01% 3273
2019
Q3
$4K Sell
200
-3,908
-95% -$71.9K ﹤0.01% 3284
2019
Q2
$76K Buy
4,108
+1,769
+76% +$35.3K ﹤0.01% 2337
2019
Q1
$57K Buy
+2,339
New +$61.2K ﹤0.01% 2434
2017
Q1
Sell
-41
Closed -$1K 3583
2016
Q4
$1K Buy
+41
New +$643 ﹤0.01% 3450

Other funds holding HRTX